
1. Sci Rep. 2020 Apr 15;10(1):6436. doi: 10.1038/s41598-020-63475-w.

Gut metagenomic and short chain fatty acids signature in hypertension: a
cross-sectional study.

Calderón-Pérez L(1)(2), Gosalbes MJ(3)(4), Yuste S(5), Valls RM(6)(7), Pedret
A(1)(2), Llauradó E(2), Jimenez-Hernandez N(3)(4), Artacho A(3)(4), Pla-Pagà
L(1)(2), Companys J(1)(2), Ludwig I(1), Romero MP(5), Rubió L(8)(9), Solà
R(1)(2)(10).

Author information: 
(1)Eurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Reus,
Spain.
(2)Universitat Rovira i Virgili, Facultat de Medicina i Ciències de la Salut,
Functional Nutrition, Oxidation, and Cardiovascular Diseases Group (NFOC-Salut), 
C/Sant Llorenç 21, 43201, Reus, Spain.
(3)Fundación para el Fomento de la Investigación Sanitaria y Biomédica, Valencia,
Spain.
(4)CIBER en Epidemiología y Salud Pública (CIBEResp), Madrid, Spain.
(5)Food Technology Department, XaRTA-TPV, Agrotecnio Center, Escola Tècnica
Superior d'Enginyeria Agrària, University of Lleida, Avda/Alcalde Rovira Roure
191, 25198, Lleida, Catalonia, Spain.
(6)Eurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Reus,
Spain. rosamaria.valls@urv.cat.
(7)Universitat Rovira i Virgili, Facultat de Medicina i Ciències de la Salut,
Functional Nutrition, Oxidation, and Cardiovascular Diseases Group (NFOC-Salut), 
C/Sant Llorenç 21, 43201, Reus, Spain. rosamaria.valls@urv.cat.
(8)Universitat Rovira i Virgili, Facultat de Medicina i Ciències de la Salut,
Functional Nutrition, Oxidation, and Cardiovascular Diseases Group (NFOC-Salut), 
C/Sant Llorenç 21, 43201, Reus, Spain. laura.rubio@udl.cat.
(9)Food Technology Department, XaRTA-TPV, Agrotecnio Center, Escola Tècnica
Superior d'Enginyeria Agrària, University of Lleida, Avda/Alcalde Rovira Roure
191, 25198, Lleida, Catalonia, Spain. laura.rubio@udl.cat.
(10)Hospital Universitari Sant Joan de Reus, Reus, Spain.

Hypertension is an independent and preventable risk factor for the development
of cardiovascular diseases, however, little is known about the impact of gut
microbiota composition in its development. We carried out comprehensive gut
microbiota analysis and targeted metabolomics in a cross-sectional study of 29
non-treated hypertensive (HT) and 32 normotensive (NT) subjects. We determined
fecal microbiota composition by 16S rRNA gene sequencing and bacterial functions 
by metagenomic analysis. The microbial metabolites analysed were short chain
fatty acids (SCFA) both in plasma and feces, and trimethylamine N-oxide (TMAO) in
plasma. The overall bacterial composition and diversity of bacterial community in
the two groups were not significantly different. However, Ruminococcaceae
NK4A214, Ruminococcaceae_UCG-010, Christensenellaceae_R-7, Faecalibacterium
prausnitzii and Roseburia hominis were found to be significantly enriched in NT
group, whereas, Bacteroides coprocola, Bacteroides plebeius and genera of
Lachnospiraceae were increased in HT patients. We found a positive correlation
between the HT-associated species and systolic and diastolic blood pressure after
adjusted for measured confounders. SCFA showed antagonistic results in plasma and
feces, detecting in HT subjects significant higher levels in feces and lower
levels in plasma, which could indicate a less efficient SCFA absorption. Overall,
our results present a disease classifier based on microbiota and bacterial
metabolites to discriminate HT individuals from NT controls in a first disease
grade prior to drug treatment.

DOI: 10.1038/s41598-020-63475-w 
PMCID: PMC7160119
PMID: 32296109 

